Literature DB >> 32930438

Severe COVID-19 infection in a child receiving immunotherapy for cancer.

Valeria R Smith1, Sarah B Whittle1, Ryan D Coleman2,3, Flor M Munoz4, Marietta M De Guzman5, Jennifer H Foster1, Shoba A Navai1.   

Abstract

Entities:  

Year:  2020        PMID： 32930438     DOI： 10.1002/pbc.28710

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

Review 1.  COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).

Authors:  Jérémie Rouger-Gaudichon; Yves Bertrand; Nicolas Boissel; Benoit Brethon; Stéphane Ducassou; Virginie Gandemer; Carine Halfon-Domenech; Thierry Leblanc; Guy Leverger; Gérard Michel; Arnaud Petit; Anne-France Ray-Lunven; Pierre-Simon Rohrlich; Pascale Schneider; Nicolas Sirvent; Marion Strullu; André Baruchel
Journal:  Bull Cancer       Date:  2021-03-11       Impact factor: 1.276

Review 2.  COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.

Authors:  Federico Mercolini; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

3.  The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review.

Authors:  Amna Majeed; Tom Wright; Biqi Guo; Ramandeep S Arora; Catherine G Lam; Alexandra L Martiniuk
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.